Floatz logo

Probenecid

Blood Pressure

Brigham and Women's HospitalSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

17 Active assets in the Blood Pressure cohort.

Asset / SponsorPhaseRating
Hydrochlorothiazide
Yuhan Corporation
Phase 4BBB
AMLODIPINE
Yuhan Corporation
Phase 4BBB
LABETALOL
ProMedica Health System
Phase 3BB
Tomato Fruit Extract
Beata Krasinska
Phase 4BB
Phentermine
VIVUS LLC
Phase 4BB

View all 44 →

Same molecule, other indications

Probenecid is also rated in:

cytomegalovirus retinitisDormant
BB
Indicative ·
69 / 100
View asset →
HIV infectious diseaseDormant
BB
Indicative ·
65 / 100
View asset →
impaired renal function diseaseDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →